CHAMELEON BIOSCIENCES

chameleon-biosciences-logo

Chameleon is changing the way they treat genetic diseases using gene therapy to deliver corrective genes using multiple systemic dose administrations. Research indicates that 20-30% of all infant fatalities are due to genetic disorders, and for those who survive, treatment options are often limited. Recent breakthroughs in gene therapy are saving lives, but there's still a long way to go. At Chameleon, their goal is to ensure every child can be treated with lower doses and accurate target specificity over time as their condition requires. They are committed to every child and family who suffers from a genetic disorder. Their mission is to make sure every Belle, Abby and Marian live to their 10th birthdays, learn to drive, go to prom and someday have healthy children of their very own.

#SimilarOrganizations #People #Financial #Website #More

CHAMELEON BIOSCIENCES

Industry:
Biotechnology Genetics Therapeutics

Founded:
2017-01-01

Address:
San Anselmo, California, United States

Country:
United States

Website Url:
http://www.chameleonbiosci.com

Total Employee:
1+

Status:
Active

Email Addresses:
geninew@chameleonbiosci.com

Total Funding:
14.2 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Sitelinks Search Box


Similar Organizations

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

imara-logo

Imara

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.


Current Advisors List

francisca-peixoto_image

Francisca Peixoto Board Observer @ Chameleon Biosciences
Board_observer
2021-07-01

Current Employees Featured

casey-maguire_image

Casey Maguire
Casey Maguire Co-Founder and Scientific Advisor @ Chameleon Biosciences
Co-Founder and Scientific Advisor
2017-08-01

genine-winslow_image

Genine Winslow
Genine Winslow Founder and CEO @ Chameleon Biosciences
Founder and CEO
2016-10-01

Founder


casey-maguire_image

Casey Maguire

genine-winslow_image

Genine Winslow

Investors List

lifelink-ventures_image

LifeLink Ventures

LifeLink Ventures investment in Seed Round - Chameleon Biosciences

tachyon-ventures_image

Tachyon Ventures

Tachyon Ventures investment in Seed Round - Chameleon Biosciences

solasta-ventures_image

Solasta Ventures

Solasta Ventures investment in Venture Round - Chameleon Biosciences

matrix-partners-china_image

Matrix Partners China

Matrix Partners China investment in Seed Round - Chameleon Biosciences

cantos-ventures_image

Cantos

Cantos investment in Seed Round - Chameleon Biosciences

life-science-angels_image

Life Science Angels

Life Science Angels investment in Seed Round - Chameleon Biosciences

berkeley-skydeck-fund_image

Berkeley SkyDeck Fund

Berkeley SkyDeck Fund investment in Seed Round - Chameleon Biosciences

Official Site Inspections

http://www.chameleonbiosci.com

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Chameleon Biosciences"

Chameleon Biosciences - Crunchbase Company Profile & Funding

Contact Email geninew@chameleonbiosci.com Chameleon is changing the way they treat genetic diseases using gene therapy to deliver corrective genes using multiple systemic dose …See details»

Chameleon Biosciences, Inc. - Drug pipelines, Patents ... - Patsnap

Www.chameleonbiosci.com. Last update 19 Sep 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Tags. ... The …See details»

Chameleon Biosciences, Inc. | LinkedIn

Chameleon Biosciences, Inc. | 696 followers on LinkedIn. Saving children's lives, one genetic disease at a time. | Chameleon Biosciences, Inc. is a gene therapy startup company based out …See details»

Chameleon Biosciences Company Profile | Management and

Www.chameleonbiosci.com Chameleon Biosciences Profile and History Chameleon Biosciences is a pre-clinical stage gene therapy company, developing a proprietary first in class vector …See details»

Chameleon Biosciences - PitchBook

Chameleon Biosciences General Information Description. Developer of a gene delivery technology designed to overcome existing treatment barriers in gene therapy. The company's …See details»

Chameleon Biosciences - Overview, News & Similar companies

Apr 28, 2022 Chameleon Biosciences contact info: Phone number: (510) 990-3089 Website: www.chameleonbiosci.com What does Chameleon Biosciences do? Chameleon Biosciences …See details»

Chameleon Biosciences Company Profile -Sales, Contacts, …

Chameleon Biosciences is in the Pharmaceutical Preparations industry within the Chemicals and Allied Products sector and has been in business for approximately 7 years.See details»

CureDuchenne Invests in Chameleon Biosciences to Support …

Sep 27, 2019 CureDuchenne is the nation’s leading nonprofit organization dedicated to finding a cure for Duchenne, the most common and lethal form of muscular dystrophy. As the leading …See details»

Chameleon Biosciences - Company Profile - Tracxn

Nov 1, 2024 Chameleon Biosciences ranks 29th among 91 active competitors. 33 of its competitors are funded while 14 have exited. Overall, Chameleon Biosciences and its …See details»

Chameleon Biosciences - VentureRadar

Similar Companies: Dyno Therapeutics USA Privately Held Dyno Therapeutics is applying AI technology to discover novel gene therapy vectors with transformative delivery properties for a …See details»

Chameleon Biosciences - VentureRadar

Chameleon Biosciences is a Berkeley-based biotech developing next-generation adeno-associated virus vectors (AAV) that have been shown to elicit less... ... Find out ...See details»

Chameleon Biosciences - Craft

Chameleon Biosciences is a company providing children's gene therapy. It develops EVADER platform technology that shields the capsid from antibodies, reduces antibody production, and …See details»

Chameleon Biosciences Appoints Silicon Valley Scientist and ...

Jan 5, 2022 BERKELEY, CA / ACCESSWIRE / January 5, 2022 / Chameleon Biosciences Inc., a company developing the EVADER TM platform to produce next-generation gene therapies …See details»

Chameleon Biosciences | A Bonneville Labs Member Company

Chameleon Biosciences was founded in 2017 in California. Innovations developed by Chameleon founders have provided the ability to design a potentially more potent, less immunogenic gene …See details»

Chameleon Biosciences - Expanding AAV Gene Therapies with …

4 as a result of clinical trials, we can then expand our platform for non-rare genetic diseases. For example, there may be a long-term application toSee details»

CureDuchenne Invests in Chameleon Biosciences to Support EVADER

Sep 27, 2019 More information about Chameleon can be found on the company’s website at www.chameleonbiosci.com. Contacts Media Contact: Joanne Forster 310.498.7585 …See details»

Chameleon Biosciences Appoints Silicon Valley Scientist and ...

Jan 5, 2022 Dr. Chalberg is a scientist, entrepreneur, and executive in Silicon Valley. He has spent the past 15 years developing novel therapies and life-changing products, particularly in …See details»

Chameleon Biosciences Presents Poster on AAV Gene Therapy …

Oct 11, 2022 -Chameleon Biosciences Inc., a biotechnology company focused on an innovative approach to produce safer, more effective gene therapies, will present "Use of EVADER AAV8 …See details»

ChameleonBiosciences - Nature

Email:jeffv@chameleonbiosci.com CONTACT Fig. 2 | EVADER human FIX production is titratable for two doses. Studies in mice have shown that treatment with an AAV8 Evader/FIX particle …See details»

Organoid bioprinting: from cells to functional tissues

4 days ago The biofabrication of complex human tissues to recapitulate organ-specific architecture and function requires a combination of engineering control and intrinsic self …See details»

linkstock.net © 2022. All rights reserved